Research

Agrovet Market Animal Health commitment to innovation is reflected in its mission to provide unique solutions to the needs of practicing veterinarians, animal health professionals, farmers, breeders and pet owners. Scientific, clinical and field research is a constant commitment, becoming a crucial part of the DNA of our company.

Fieldwork

doraQuest® l.a.

Evaluation of the Efficacy and Tolerance of an oral gel endectocide based on Doramectin (doraQuest® l.a.) ® )* in the treatment of internal parasites in show jumper horses.

Fieldwork

Cloxantel Inyectable 10%

Efficacy and tolerance evaluation of injectable solution based on Closantel 10% ( Cloxantel Injection 10%) associated with an antiparasite oral suspension based on Fenbendazole ( FBZ ® 12.5 % with minerals) in treatment against Fasciola hepatica (liver flukes) and gastrointestinal nematodes in alpacas in the Central Sierra (Junín).

Fieldwork

Bovimec® L.A. AD3E

Antihelmintic tolerance evaluation on weight gain, on the applying area of inyectable solution Ivermectin 1% long-acting associated with Vitamin A 2,500,000 IU , 375,000 IU D3 and E 2.5 g per 100 mL of product ( Bovimec LA + AD3E ) in cattle grazing.

Fieldwork

Bovimec®

Antihelmintic tolerance and efficacy evaluation of injectable solution Ivermectin 1% ( Bovimec ® ) in pigs

Fieldwork

Bovimec®

Antihelmintic tolerance and efficacy evaluation of injectable solution Ivermectin 1% ( Bovimec ® ) in intensive fattening cattle .

Fieldwork

Bovimec®

Evaluation of the efficacy and tolerance of injectable solution based on Ivermectin ( Bovimec ) * to control tick infestations (Boophilus microplus ) and larvae fly ( Dermatobia hominis ) in beef cattle from Peru jungle.

Fieldwork

Bovimec® Etiqueta Azul 3.15%

Antihelmintic efficacy against ectoparasites (boophilus microplus and dermatobia hominis larvae ) of injectable solution Ivermectin 3.15% ( Bovimec ® Blue Label 3.15 %) in intensive fattening of cattle naturally infested.

Fieldwork

Bovimec® Etiqueta Azul 3.15%

Formulation tolerance and anti-nematodic efficacy evaluation based on Ivermectin 3.15% long-acting ( Bovimec ® Blue Label 3.15 %) in alpacas .